We are live on ! Find out more
CSPIA

Cary Street Partners Investment Advisory Portfolio holdings

AUM $494M
1-Year Est. Return 27.12%
This Fund
S&P 500
This Quarter Est. Return
+5.74%
1 Year Est. Return
+27.12%
3 Year Est. Return
+84.09%
5 Year Est. Return
+94.67%
10 Year Est. Return
AUM
$1.56B
AUM Growth
+$164M
Cap. Flow
+$94.6M
Cap. Flow %
6.08%
Top 10 Hldgs %
18.51%
Holding
1,811
New
134
Increased
495
Reduced
356
Closed
61
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VFC icon
1051
VF Corp
VFC
$5.73B
$19.5K ﹤0.01%
1,024
PPA icon
1052
Invesco Aerospace & Defense ETF
PPA
$8.68B
$19.5K ﹤0.01%
231
+227
+5,675% +$18.3K
SMG icon
1053
ScottsMiracle-Gro
SMG
$3.62B
$19.4K ﹤0.01%
310
XIFR
1054
XPLR Infrastructure LP
XIFR
$1.08B
$19.2K ﹤0.01%
328
-20
-6% -$1.2K
SCL icon
1055
Stepan Co
SCL
$1.48B
$19.1K ﹤0.01%
200
ROST icon
1056
Ross Stores
ROST
$79.6B
$19.1K ﹤0.01%
170
TTC icon
1057
Toro Company
TTC
$9.32B
$19K ﹤0.01%
187
+25
+15% +$2.56K
EEMV icon
1058
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.61B
$19K ﹤0.01%
345
-136
-28% -$7.52K
IYG icon
1059
iShares US Financial Services ETF
IYG
$2.24B
$19K ﹤0.01%
360
OGN icon
1060
Organon & Co
OGN
$3.59B
$18.9K ﹤0.01%
910
-258
-22% -$5.61K
HZNP
1061
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$18.8K ﹤0.01%
183
HACK icon
1062
Amplify Cybersecurity ETF
HACK
$3.08B
$18.8K ﹤0.01%
372
-375
-50% -$17.9K
RKT icon
1063
Rocket Companies
RKT
$42.6B
$18.8K ﹤0.01%
2,100
VERV
1064
DELISTED
Verve Therapeutics
VERV
$18.8K ﹤0.01%
1,000
-300
-23% -$5K
ETG
1065
Eaton Vance Tax-Advantaged Global Dividend Income Fund
ETG
$1.87B
$18.7K ﹤0.01%
1,120
-645
-37% -$10.4K
MSD
1066
Morgan Stanley Emerging Markets Debt Fund
MSD
$147M
$18.7K ﹤0.01%
2,900
CBRL icon
1067
Cracker Barrel
CBRL
$1.31B
$18.6K ﹤0.01%
200
VTRS icon
1068
Viatris
VTRS
$18.5B
$18.6K ﹤0.01%
1,863
-111
-6% -$1.06K
PDT
1069
John Hancock Premium Dividend Fund
PDT
$626M
$18.6K ﹤0.01%
1,576
XLRE icon
1070
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.68B
$18.5K ﹤0.01%
492
-48
-9% -$1.77K
BAX icon
1071
Baxter International
BAX
$13.9B
$18.5K ﹤0.01%
405
+1
+0.2% +$44
IONR
1072
Ioneer
IONR
$255M
$18.4K ﹤0.01%
2,025
BJ icon
1073
BJs Wholesale Club
BJ
$11.8B
$18.4K ﹤0.01%
292
+79
+37% +$5.46K
KNF icon
1074
Knife River
KNF
$3.83B
$18.3K ﹤0.01%
+420
New +$17.8K
AOS icon
1075
A.O. Smith
AOS
$8.51B
$18.2K ﹤0.01%
250

Similar funds

Cary Street Partners Investment Advisory's Q2 2023 Portfolio in Review

As of Q2 2023, Cary Street Partners Investment Advisory held 1,811 positions worth $1.56B, up 12% from $1.39B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Cary Street Partners Investment Advisory deployed $94.6M of net new capital in Q2 2023, opening 134 new positions and adding to 495 existing holdings. Its largest new stake was Franklin International Core Dividend Tilt Index ETF: 202,350 shares worth $5.91M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares Ultra Short Duration Bond Active ETF, an estimated $7.96M trimmed.

  • Cary Street Partners Investment Advisory's largest Q2 2023 buy was Franklin International Core Dividend Tilt Index ETF: 202,350 shares worth $5.91M.
  • Cary Street Partners Investment Advisory added most to Vanguard Intermediate-Term Bond ETF in Q2 2023, an estimated $15.7M increase.
  • Cary Street Partners Investment Advisory's biggest Q2 2023 reduction was iShares Ultra Short Duration Bond Active ETF, cutting an estimated $7.96M.
  • Cary Street Partners Investment Advisory fully exited SPDR S&P 600 Small Cap ETF (based on S&P SmallCap 600 Index--symbol SML) in Q2 2023, selling an estimated $12M.
  • Cary Street Partners Investment Advisory's ten largest holdings make up 19% of its $1.56B portfolio in Q2 2023.
  • Cary Street Partners Investment Advisory opened 134 new positions and closed 61 in Q2 2023.
  • Cary Street Partners Investment Advisory's portfolio value rose 12% quarter-over-quarter to $1.56B.

Based on Cary Street Partners Investment Advisory's 13F filing for Q2 2023, filed 10 Aug 2023.